Annual Retained Earnings
-$179.38 M
-$35.81 M-24.94%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual retained earnings is -$179.38 million, with the most recent change of -$35.81 million (-24.94%) on December 31, 2023.
- During the last 3 years, EFTR annual retained earnings has fallen by -$42.68 million (-31.22%).
- EFTR annual retained earnings is now -48.37% below its all-time high of -$120.90 million, reached on December 31, 2021.
Performance
EFTR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$188.21 M
-$8.83 M-4.92%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly retained earnings is -$188.21 million, with the most recent change of -$8.83 million (-4.92%) on March 31, 2024.
- Over the past year, EFTR quarterly retained earnings has dropped by -$34.63 million (-22.55%).
- EFTR quarterly retained earnings is now -59.73% below its all-time high of -$117.83 million, reached on March 31, 2022.
Performance
EFTR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
EFTR Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.9% | -22.6% |
| 3 y3 years | -31.2% | -22.6% |
| 5 y5 years | -31.2% | -22.6% |
EFTR Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.4% | at low | -59.7% | at low |
| 5 y | 5-year | -48.4% | at low | -59.7% | at low |
| alltime | all time | -48.4% | at low | -59.7% | at low |
EFFECTOR Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -$188.21 M(+4.9%) |
| Dec 2023 | -$179.38 M(+24.9%) | -$179.38 M(+5.4%) |
| Sep 2023 | - | -$170.25 M(+5.1%) |
| Jun 2023 | - | -$161.94 M(+5.4%) |
| Mar 2023 | - | -$153.58 M(+7.0%) |
| Dec 2022 | -$143.57 M | -$143.57 M(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -$134.31 M(+7.7%) |
| Jun 2022 | - | -$124.75 M(+5.9%) |
| Mar 2022 | - | -$117.83 M(-2.5%) |
| Dec 2021 | -$120.90 M(-11.6%) | -$120.90 M(-13.6%) |
| Sep 2021 | - | -$139.95 M(+2.4%) |
| Dec 2020 | -$136.70 M | -$136.70 M |
FAQ
- What is eFFECTOR Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual retained earnings year-on-year change?
- What is eFFECTOR Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly retained earnings year-on-year change?
What is eFFECTOR Therapeutics annual retained earnings?
The current annual retained earnings of EFTR is -$179.38 M
What is the all time high annual retained earnings for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual retained earnings is -$120.90 M
What is eFFECTOR Therapeutics annual retained earnings year-on-year change?
Over the past year, EFTR annual retained earnings has changed by -$35.81 M (-24.94%)
What is eFFECTOR Therapeutics quarterly retained earnings?
The current quarterly retained earnings of EFTR is -$188.21 M
What is the all time high quarterly retained earnings for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly retained earnings is -$117.83 M
What is eFFECTOR Therapeutics quarterly retained earnings year-on-year change?
Over the past year, EFTR quarterly retained earnings has changed by -$34.63 M (-22.55%)